Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Because the regenerative capacity of adult heart is limited, any substantial cell loss as a result of a heart attack is mostly irreversible and may lead to progressive heart failure.…

Continue ReadingPreclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model

Epigenetic regulation of human cardiac differentiation

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Each cell type in our body has its own identity. This identity allows a heart cell to contract repetitively, and a brain cell to conduct nerve impulses. Each cell type…

Continue ReadingEpigenetic regulation of human cardiac differentiation

Induction of Pluripotent Stem Cell-Derived Pacemaking Cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Currently, over 350,000 patients per year with abnormal heart rhythm receive electronic pacemakers to restore their normal heart beat. Electronic pacemakers do not respond to the need for changing heart…

Continue ReadingInduction of Pluripotent Stem Cell-Derived Pacemaking Cells

Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Most heart conditions leading to sudden death or impaired pumping heart functions in the young people (

Continue ReadingStudying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells

Mechanism of heart regeneration by cardiosphere-derived cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

In the process of a heart attack, clots form suddenly on top of cholesterol-laden plaques, blocking blood flow to heart muscle. As a result, living heart tissue dies and is…

Continue ReadingMechanism of heart regeneration by cardiosphere-derived cells

A new paradigm of lineage-specific reprogramming

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Recently, we devised and reported a new regenerative medicine paradigm that entails temporal/transient overexpression of induced pluripotent stem cell based reprogramming factors in skin cells, leading to the rapid generation…

Continue ReadingA new paradigm of lineage-specific reprogramming

Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Patients with end-stage heart failure have a 2-year survival rate of only 50% with conventional medical therapy. This dismal survival rate is actually significantly worse than patients with AIDS, liver…

Continue ReadingHuman Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure

Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction

  • Post author:
  • Post published:May 20, 2025
  • Post category:

The proposed research will demonstrate both safety and efficacy of a heart-derived stem cell product in patients who have experienced a heart attack either recently or in the past by…

Continue ReadingAllogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction

Direct Cardiac Reprogramming for Heart Regeneration

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Heart disease is a leading cause of mortality. The underlying pathology is typically loss of heart muscle cells that leads to heart failure. Because heart muscle has little or no…

Continue ReadingDirect Cardiac Reprogramming for Heart Regeneration

Human ES cell based therapy of heart failure without allogenic immune rejection

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Heart failure is a major and ever-growing health problem affecting an estimated 5.8 million Americans with about half a million new cases every year. There are limited therapeutic options for…

Continue ReadingHuman ES cell based therapy of heart failure without allogenic immune rejection
  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us